| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Endocrine Institute (R.L.), Haemek Medical Center, Endocrine Laboratory (Z.S.O.), Rambam Medical Center, Haifa 32000, Israel; and The Sleep Research Center (Z.Z., P.H., P.L.), Technion, Israel Institute of Technology, Haifa 32000, Israel
Address all correspondence and requests for reprints to: Prof. R. Luboshitzky, Endocrine Institute, Haemek Medical Center, Afula 18101, Israel.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The present study was undertaken to further delineate whether the nocturnal testosterone rhythm is sleep related or whether this rhythm is controlled by the circadian clock. We used the 7/13 ultrashort paradigm (10, 11, 12), whereas subjects were partially sleep deprived and had fragmented sleep. Melatonin onset and core body temperature were used as circadian markers (12).
| Subjects and Methods |
|---|
|
|
|---|
Ten healthy men (aged 2226 yr) volunteered to participate in the study. All were in good health, nonsmoking, within 10% of ideal body weight and received no medications. The study was approved by the Helsinki Committee of the Medical Center, Afula, Israel. All participants gave their informed consent before the onset of the study.
Study protocol
Subjects were admitted to the Sleep Research Center between 2200
and 2300 h. They slept between 0100 and 0600 h for
habituation, with electrodes attached for sleep recordings. At
0600 h, an iv catheter was inserted into an antecubital vein, kept
patent by a slow infusion of 0.9% NaCl. At 0700 h, subjects began
a schedule of 7 min sleep, 13 min awake, for 24 h (7/13 ultrashort
sleep paradigm) as previously described (10). In brief,
every 20 min, subjects were instructed to be in bed in a dark room and
attempt to fall asleep. Electrophysiological recordings were carried
out during the 7 min sleep attempts (in a completely darkened room) to
determine the sleep stages. At the end of the 7-min trials, whether
asleep or awake, subjects were asked to leave the bedroom. Light
intensity during the 13-min intervening wake period was
50 lx. This
cycle was repeated 72 times, until 0700 h the next day. A large
number of studies using this paradigm have revealed that subjects
adapted to the fragmented sleep without difficulties and that the
pattern of sleep propensity obtained with this paradigm is very stable
and reliable (10, 11, 13).
Blood samples (3 mL) were collected every 20 min in between sleep attempts, from 1900 h-0700 h. Liquid food (Ensure plus) providing complete balanced nutrition of 355cal/237 mL (Abbott Laboratories, Columbus, Ohio) was given every 3 h.
Results of sleep recordings and serum testosterone levels in this group (fragmented sleep) were compared with a group of six healthy men of similar age (aged 2125 yr) during continuous sleep between 22000700 h as previously described (9). Throughout the study, core body temperature was recorded once per minute using Minilogger 2000 (Mini-Mitter) with the YSI, Inc. 400 disposable rectal probe.
Analysis of sleep stages
Electrodes were attached for the following electrophysiological recordings: two electroencephalograms (EEG levels C3-A2, C4-A1), two electrooculograms, and one electromyogram of the mentalis. Sleep stages were recorded in 30 sec epochs according to conventional criteria. Each of the 7-min trials was scored for sleep stages 1,2, 3/4, and REM according to previously described criteria (13). As reported before (14), the sleep propensity function obtained by the 7/13 paradigm is characterized by three features: an evening nadir in sleepiness (the forbidden zone for sleep), the sleep gate, and the nocturnal crest in sleepiness. The sleep gate, which represents an abrupt increase in sleep propensity from a low level during the forbidden zone to the nocturnal crest, was determined as described before (15). It was the trial during which subjects obtained at least 3.5 min of sleep of any stage followed by at least 5 of 6 trials meeting the same criterion. Latency to first REM episode in the 7/13 paradigm was calculated as the time between the sleep gate and the first appearance of at least 30 sec of REM sleep in any of the 7-min sleep attempts. Sleep data in the continuous sleep group were analyzed by conventional methods to determine sleep latency, sleep stages and REM latency. REM latency in this condition was the time from sleep onset to the first appearance of REM sleep.
Testosterone measurements
Blood was centrifuged, immediately separated, and stored at -20 C until assayed. Serum testosterone levels were determined by RIA (Diagnostic Products Corp., Los Angeles, CA). The intraassay coefficients of variations (CV) were 6.0% and 3.0% for low (2.24.0 nmol/L) and high (29.462.0 nmol/L) concentrations, respectively. The interassay CVs were 1.9% and 1.6%, respectively. The sensitivity of the assay was 0.15 nmol/L.
Melatonin measurements
Serum melatonin levels were determined every 20 min between 1900 and 0000 h by RIA (Bühlmann Laboratory, Albshwill, Switzerland). The assay sensitivity was 2.0 pmol/L. The intraassay CVs were 4.9% and 5.8% for low (412 pmol/L) and high (42106 pmol/L) concentrations, respectively. The interassay CVs were 7.8% and 6.7%, respectively.
Statistical analysis
Mean serum testosterone levels, the integrated nocturnal testosterone values (area under the curve; AUC) from 1900 to 0700 h were determined in the two groups. The onset of the nocturnal melatonin rise was defined as the time when melatonin levels exceeded 10 pmol/L with subsequent samples until 0000 h being higher than this value. Prior samples revealed melatonin concentrations between 2.010.0 pmol/L.
The onset of the testosterone rise was defined as the time of the first occurrence of at least three consecutive samples exceeding the mean levels obtained between 1900 and 2100 h more than 1 SD.
Independent two-sample t tests were used to compare the mean testosterone levels and AUC, between the subjects who had REM sleep episodes and those who did not have REM in the 7/13 sleep group. Also, independent two-sample t tests were used to compare the same testosterone parameters of the fragmented sleep group with the continuous sleep group. The testosterone curves were modeled as three separate fractions: before testosterone rise, between testosterone rise and first REM, and after the first REM. The mean slope of the linear regression lines fitted to the middle fraction of the testosterone curves was correlated with REM latency. We also used t tests to determine whether each group had a nonzero slope and whether the two groups had statistically significant different slopes. Independent two-sample t tests were used to compare the mean sleep stages (percent) between the subjects during fragmented and continuous sleep.
| Results |
|---|
|
|
|---|
|
|
|
|
To further investigate the possible presence of a circadian rhythm in
testosterone secretion, we synchronized testosterone levels, according
to the sleep gate in the 7/13 paradigm group, to sleep onset time in
the continuous sleep condition and then, according to the nocturnal
melatonin onset in each condition (Table 2
). During continuous sleep,
nocturnal rise in testosterone was evident when hormone levels were
synchronized with either sleep onset time or with melatonin onset time
(Fig. 3
). During fragmented sleep,
nocturnal testosterone rise was evident only in subjects with REM. The
testosterone rise occurred when hormone levels were synchronized with
either melatonin onset time (Fig. 4A
) or
with the sleep gate (Fig. 4B
). To examine the differences between
subjects with and without REM sleep, core body temperature (CBT) and
melatonin data were averaged separately for the two groups (data not
shown). Subjects with REM tended to have earlier peaks in CBT
(18:20 ± 0:10) and melatonin onset (22:00 ± 0:41) than
subjects without REM (19:40 h ± 0:14 and 22:52 h ± 0:41,
respectively).
|
|
| Discussion |
|---|
|
|
|---|
Diurnal rhythm of testosterone already exists at 45 yr of age (16). In adult men, the diurnal testosterone rhythm revealed higher levels at night and minimal in the late evening. The amplitude of the rhythm being approximately 20% of the mean testosterone level (7, 17, 18).
The effect of advancing age on the chronobiology of testosterone and LH in healthy young and elderly men were investigated. Both young and elderly men had significant diurnal rhythms in serum testosterone although the rhythm in elderly men was attenuated compared with the young. Mean LH levels did not vary over the 24 h period in both young and elderly men (19). Blunted testosterone rhythm was also observed in young men with testicular failure (20).
Several factors may be expected to influence the diurnal rhythm of testosterone. Among these are LH, diurnal changes in Leydig cells response to LH, intrinsic levels of gonadal factors such as inhibin-ß, the circadian clock, sleep related processes or sleep associated variations in testicular blood flow. In healthy adult men, testosterone rhythm was positively correlated with serum inhibin-ß rhythm with higher values in the early morning hours and lower values in the evening (21).
Whereas in pubertal boys, sleep-related LH elevations are common (17, 22), only 15% of adult men have sleep-related LH elevations (22, 23, 24), and there is no clear circadian rhythm (17, 19). Therefore, it is likely that the robust diurnal testosterone rhythm is only partially controlled by LH. The hypothesis that the diurnal testosterone rhythm is driven by the circadian clock (7, 17) was not supported by our findings. Synchronizing testosterone levels to melatonin onset did not reveal any change in testosterone levels in the fragmented sleep condition. In contrast, the nocturnal rise in melatonin is independent of sleep and was shown to persist in the 7/13 paradigm in the present study and in a previous report (12).
Cooke et al. (25) have demonstrated that the major factors implicated in the testosterone rhythm amplitude were increasing saturation of the binding proteins following rise in testosterone production and the changes in protein concentration related to postural changes. The authors also suggested that the rise in cortisol concentration in the early morning by competing with testosterone for albumin binding sites, may be responsible for the diurnal testosterone rhythm.
It cannot be excluded that changes in posture also contributed to our results. On lying down there is a decrease in protein concentration that is considered to be due to a shift of fluid into the vascular compartment under decreased hydrostatic pressure. This may cause dilution of nondiffusable compounds present in serum (25). In our study during fragmented sleep, subjects were recumbent for the 7-min sleep attempts and then they left the bedroom for 13 min, at which time they were ambulatory. During continuous sleep, subjects were always recumbent from 22000700 h. Therefore, it is possible that changes in postures may have contributed to the loss of the night-time rise in testosterone levels. However, dependency of testosterone rise on REM sleep observed during the 7/13 paradigm as previously observed during continuous sleep is hardly explained by postural changes.
Our present results confirm that the rise in testosterone is related to the appearance of the first REM episode of the night. This is supported by the significant relationship between REM latency and the slope of the testosterone rise, the difference in the slopes of testosterone between subjects with and without REM episodes during fragmented sleep, and by the findings in one of the subjects who had several REM episodes without testosterone rise. This man had sustained elevated testosterone levels above the threshold of 13 nmol/L. This threshold was suggested as partially responsible for initiating nocturnal penile tumescence at about the time of the first REM sleep episode (26). Previous studies have shown that a single circadian oscillator controls REM sleep, core body temperature, and melatonin (27). Assuming that the same oscillator was controlling testosterone, we anticipated the persistence of the diurnal testosterone rhythm under fragmented sleep condition. However, the lack of circadian rhythm in testosterone under the 7/13 paradigm, even when synchronized to melatonin onset, precludes such an explanation. Thus, it is possible that the testosterone rhythm is dependent on a specific phase relationship between sleep and the underlying circadian oscillator, rather than on the circadian oscillator per se. Further studies should elaborate this possibility.
| Acknowledgments |
|---|
Received May 1, 2000.
Accepted November 8, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. O. Hammoud, M. Gibson, C. M. Peterson, B. D. Hamilton, and D. T. Carrell Obesity and Male Reproductive Potential J Androl, September 1, 2006; 27(5): 619 - 626. [Full Text] [PDF] |
||||
![]() |
H. K. Yaggi, A. B. Araujo, and J. B. McKinlay Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care, March 1, 2006; 29(3): 657 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Lavoie, E. E. Marsh, and J. E. Hall Absence of Apparent Circadian Rhythms of Gonadotropins and Free {alpha}-Subunit in Postmenopausal Women: Evidence for Distinct Regulation Relative to Other Hormonal Rhythms J Biol Rhythms, February 1, 2006; 21(1): 58 - 67. [Abstract] [PDF] |
||||
![]() |
J. Axelsson, M. Ingre, T. Akerstedt, and U. Holmback Effects of Acutely Displaced Sleep on Testosterone J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4530 - 4535. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saaresranta and O. Polo Sleep-disordered breathing and hormones Eur. Respir. J., July 1, 2003; 22(1): 161 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Luboshitzky, Z. Shen-Orr, and P. Herer Middle-Aged Men Secrete Less Testosterone at Night Than Young Healthy Men J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3160 - 3166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Luboshitzky, A. Aviv, A. Hefetz, P. Herer, Z. Shen-Orr, L. Lavie, and P. Lavie Decreased Pituitary-Gonadal Secretion in Men with Obstructive Sleep Apnea J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3394 - 3398. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |